Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/1999
06/03/1999WO1999026583A2 Inhibtion of lipoprotein oxidation
06/03/1999WO1999026582A2 Mitochondrially targeted compounds
06/03/1999WO1999026556A1 Biodegradable intra vaginal devices
06/03/1999WO1999026535A1 Reagent for tumor therapy and/or imaging
06/03/1999WO1999026476A1 New psoralens for pathogen inactivation
06/03/1999WO1999018939A9 Methods of treating capsules and dry, powdered pharmaceutical formulations
06/03/1999WO1999015656A3 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
06/03/1999WO1999014242A3 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
06/03/1999WO1999013871A3 Fused imidazole derivatives for improving oral bioavailability of pharmaceutical agents
06/03/1999WO1999013819A3 Composition and method for reducing stinging in skin
06/03/1999WO1999012951A8 Uses of nicotinamide adenine dinucleotide and its analogs for treatment of malignant and infectious diseases
06/03/1999WO1999012566A9 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF
06/03/1999WO1999011275A3 Use of immunostimulatory oligonucleotides for preventing or reducing antigen-stimulated, granulocyte-mediated inflammation
06/03/1999WO1999010312B1 N-alkanoylphenylalanine derivatives
06/03/1999WO1999007418A3 Sterile bioerodible implant device with improved biocompatability and method
06/03/1999WO1999006422A3 Base analogues
06/03/1999WO1999005096A3 Urokinase inhibitors
06/03/1999WO1999002502A3 Sulphonamide derivatives being 5-ht6 receptor antagonists and process for their preparation
06/03/1999WO1998037089A8 Matrix derived anti-hiv peptides and transdominant proteins
06/03/1999CA2641217A1 Treatment of cancer using cytokine-expressing polynucleotides and compositions therefor
06/03/1999CA2592380A1 Treatment of cancer using cytokine-expressing polynucleotides and compositions therefor
06/03/1999CA2316340A1 Phospholipids having antimicrobial activity with or without the presence of antimicrobials
06/03/1999CA2314096A1 Nuclear receptor ligands and ligand binding domains
06/03/1999CA2311969A1 Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors
06/03/1999CA2311809A1 Method for inhibiting premature rupture of fetal membranes, ripening of uterine cervix and preterm labor
06/03/1999CA2311736A1 Therapeutic treatment for chronic myeloid leukemia and acute lymphoid leukemia
06/03/1999CA2311642A1 Method for preparing adenovirus vectors, vectors so prepared, and uses thereof
06/03/1999CA2311581A1 Nucleoside analog compositions and uses thereof
06/03/1999CA2311498A1 Choline esters of fatty acids and their use in the treatment of stroke
06/03/1999CA2311448A1 Androgenic steroid compounds and a method of making and using the same
06/03/1999CA2311422A1 Citicoline to treat motor neuron diseases and demyelinating diseases
06/03/1999CA2311235A1 Method of mobilizing hematopoietic stem cells
06/03/1999CA2311131A1 Metabotropic glutamate receptor antagonists for treating central nervous system diseases
06/03/1999CA2311129A1 Use of substituted diphenyl indanone, indane and indole compounds for the treatment or prevention of sickle cell disease, inflammatory diseases characterized by abnormal cell proliferation, diarrhea and scours
06/03/1999CA2311126A1 Application of substituted aminomethyl chromans in order to prevent neural degeneration and to promote neural regeneration
06/03/1999CA2310841A1 Reagent for tumor therapy and/or imaging
06/03/1999CA2310773A1 Use of substituted 11-phenyl-dibenzazepine compounds for the treatment or prevention of sickle cell disease, inflammatory diseases characterized by abnormal cell proliferation, diarrhea and scour
06/03/1999CA2310750A1 Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment or prevention of diseases characterized by abnormal cell proliferation
06/03/1999CA2310422A1 Low-molecular heparin modification and remedy for skin ulcer
06/03/1999CA2310407A1 Formulations comprising dissolved paroxetine
06/03/1999CA2310401A1 Alpha-hydroxy, -amino and -halo derivatives of beta-sulfone hydroxamates as matrix metalloproteinase inhibitors
06/03/1999CA2310331A1 Biphenylamidine derivatives
06/03/1999CA2310069A1 Combination of an aldose reductase inhibitor and a glycogen phosphorylase inhibitor
06/03/1999CA2309888A1 Decreasing cell proliferation by decreasing levels of pp5
06/03/1999CA2309855A1 Testosterone inhibitors and use for the protection of neurons
06/03/1999CA2309358A1 A-33 related antigens and their pharmacological uses
06/03/1999CA2309341A1 Substituted .beta.-alanine derivatives as cell adhesion inhibitors
06/03/1999CA2309338A1 Cyclic amino acid derivatives as cell adhesion inhibitors
06/03/1999CA2309204A1 1,3,4-thiadiazoles and 1,3,4-oxadiazoles as .alpha.v.beta.3 antagonists
06/03/1999CA2303864A1 Inhibition of lipoprotein oxidation
06/03/1999CA2255318A1 Combination therapy
06/02/1999EP0919628A1 Process for producing high-molecular-weight compounds of phenolic compounds, etc. and use thereof
06/02/1999EP0919622A2 Surface expression of enzyme in gene directed prodrug therapy
06/02/1999EP0919568A1 Escape mutant of the surface antigen of hepatitis B virus
06/02/1999EP0919563A2 Synthetic Core 2-Like Branched Structures as Ligands for Selectins
06/02/1999EP0919554A1 Imidazole-substituted quinoxalinedione derivatives
06/02/1999EP0919553A1 cis-SUBSTITUTED AMINOCYCLOPROPANE DERIVATIVES
06/02/1999EP0919550A1 Pseudopolymorphic forms of 2-2-4-bis(4-fluorophenyl)methyl-1-piperazinyl-ethoxy acetic acid dihydrochloride
06/02/1999EP0919544A1 Compounds useful for treating allergic and inflammatory diseases
06/02/1999EP0919541A1 Naphthalene compounds, process for their preparation and their pharmaceutical compositions
06/02/1999EP0919538A1 Substituted kynurenines, a process for their preparation, and use as medicaments
06/02/1999EP0919245A2 NK-1 receptor antagonist and a systemic antiinflammatory corticosteroid for the treatment of emesis
06/02/1999EP0919244A2 Combinations for the treatment of tumours
06/02/1999EP0919239A1 Pharmaceutical composition for the treatment of acute gastroenteritis comprising a rehydration solution.and a compound with synergistic action
06/02/1999EP0919237A1 Apoptosis inducers
06/02/1999EP0919236A1 Use of a norepinephrine uptake inhibitor for the treatment of oppositional defiant disorder
06/02/1999EP0919235A1 Use of a norepinephrine reuptake inhibitor for the treatment of conduct disorder
06/02/1999EP0919234A2 Potentiation of pharmaceuticals by moxonidine
06/02/1999EP0919233A1 Therapeutic agent for kidney diseases
06/02/1999EP0919232A1 Composition for use in the treatment and prevention of hyperuricemia
06/02/1999EP0919230A1 NMIFA's as anti-inflammatory agents in superficial mammal tissues
06/02/1999EP0919229A2 Anti-reactive anti-asthmatic activity of non-steroidal anti-inflammatory drugs by inhalation
06/02/1999EP0919187A1 X-Ray imaging
06/02/1999EP0918864A2 PROTEINS, IN PARTICULAR MEMBRANE PROTEINS, OF $i(HELICOBACTER PYLORI), THEIR PREPARATION AND USE
06/02/1999EP0918859A1 Testis-specific insulin homolog polypeptides
06/02/1999EP0918857A1 Human induced tumor protein
06/02/1999EP0918848A1 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with rna
06/02/1999EP0918792A1 Dipeptide benzamidine as a kininogenase inhibitor
06/02/1999EP0918790A1 Polycationic sterol derivatives as transfection agents
06/02/1999EP0918787A1 Compositions and methods for antisense inhibition of protein translation
06/02/1999EP0918785A1 Cellular injury response element and uses thereof
06/02/1999EP0918784A1 Alkylated nucleoside-3'-phosphates, process for producing them and their use
06/02/1999EP0918783A1 6-o-substituted erythromycins and method for making them
06/02/1999EP0918777A1 SELECTED DERIVATIVES OF K-252a
06/02/1999EP0918776A1 Total synthesis of antitumor acylfulvenes
06/02/1999EP0918774A1 Androgen receptor modulator compounds and methods
06/02/1999EP0918772A1 Mesylate dihydrate salts of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2(1h)-indol-2-one (=ziprasidone), its preparation and its use as dopamine d2 antagonist
06/02/1999EP0918771A1 Thiadioxobenzodiazepine inhibitors of farnesyl protein transferase
06/02/1999EP0918770A1 Pyridyl-piperazinyl-phenyl-oxazolidinone derivatives and their use as antibacterials
06/02/1999EP0918769A1 Substituted piperazinyl-phenyl-oxazolidinone derivatives and their use as anti-bacterial agents
06/02/1999EP0918768A1 Aromatic amidine derivatives useful as selective thrombin inhibitors
06/02/1999EP0918767A1 Pharmaceutical for treating of neurological and neuropsychiatric disorders
06/02/1999EP0918761A1 Certain amido- and amino-substituted benzylamine derivatives; a new class of neuropeptite y1 specific ligands
06/02/1999EP0918760A1 Biologically active benzothiazolone ethanamines
06/02/1999EP0918759A1 Novel thiazolidone-2 derivatives, 4-diketone substituted, method for obtaining them and pharmaceutical compositions containing same
06/02/1999EP0918758A1 Process for preparing 1-substituted 4-cyano-1,2,3-triazoles
06/02/1999EP0918757A1 8-hydrocarbyl substituted benzodizocine derivatives, their preparation and their use as protein kinase c (=pkc) modulators
06/02/1999EP0918756A1 Parasiticidal pyrazoles
06/02/1999EP0918754A1 Anthranilic acid diamides derivatives, their preparation and pharmaceutical use as anti-gastrin agents
06/02/1999EP0918752A2 Dna-binding indole derivatives, their prodrugs and immunoconjugates as anticancer agents
1 ... 6492 6493 6494 6495 6496 6497 6498 6499 6500 6501 6502 6503 6504 6505 6506 6507 6508 6509 6510 6511 6512 ... 7860